Xiamen C&D (SHA: 600153) is a modern service-oriented enterprise with supply chain operation and real estate development as its main businesses.
Phone: +86-592-2263333
43F, C&D International Building
No.1699 Huandao East Road
Xiamen, 361008
Fujian, China
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-09-22 | Nucarf | Series A | Eastern Bell Capital | |
2020-08-31 | Ezisurg Medical | Series C | Hillhouse Capital Management | |
2020-07-06 | Zongteng Group | Series C | $71.2M | Ancheng Capital, Fuzhou Financial Holding Group, Taikang Life Insurance Company, and Zheshang Innovation Capital |
2020-05-28 | Ezisurg Medical | Series B - II | BioTrack Capital, Huimingwu, and Pudong Science & Technology Investment | |
2020-05-09 | Novast Pharmaceuticals | Private Equity | $141.36M | China Merchants Capital, HighLight Capital, Highsino, Legend Capital, and Shiyu Capital |